| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunic, Inc. (IMUX) has 12 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. IMUX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.72M | $20.10M | - | |
| CFO | 560.0K | $6.54M | - | |
| Other | 330.0K | $3.86M | - | |
| COO | 330.0K | $3.86M | - | |
| Other | 315.0K | $3.68M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Nash Duane | Executive Chairman | Buy | 20,000 | $0.83 | $16,694.00 | +124.8% | +5.9% | - | |
| Jun 5, 2025 | Tardio Jason | President And COO | Buy | 12,512 | $0.79 | $9,884.48 | New | +4.1% | - | |
| Jun 5, 2025 | Neermann Joerg60 | Director | Buy | 100,000 | $0.77 | $76,700.00 | +37.0% | +4.1% | - | |
| Jun 4, 2025 | Vitt Daniel | CEO And Director | Buy | 15,000 | $0.77 | $11,550.00 | +107.1% | +3.1% | - | |
| Jun 3, 2025 | Rudick Richard Alan | Director | Buy | 143,075 | $0.70 | $100,023.73 | +163.9% | +9.4% | - | |
| Jun 3, 2025 | Whaley Glenn | Chief Financial Officer | Buy | 45,000 | $0.71 | $32,076.00 | +89.1% | +9.4% | - | |
| Nov 12, 2024 | Rudick Richard Alan | Director | Buy | 87,300 | $1.15 | $100,368.81 | New | -16.5% | -33.9% | |
| Feb 26, 2024 | Vitt Daniel | President And CEO | Buy | 14,000 | $1.31 | $18,333.00 | +3.7% | -2.3% | -10.2% | |
| May 15, 2023 | Whaley Glenn | Chief Financial Officer | Buy | 5,000 | $1.75 | $8,750.00 | +24.4% | +2.8% | -27.3% | |
| Dec 14, 2022 | Neermann Joerg60 | Director | Buy | 82,000 | $1.25 | $102,642.00 | +115.5% | +39.7% | +15.9% |